Patients with diabetes mellitus who use GLP-1 RAs have an increased risk for acute and chronic pancreatitis, according to a study presented at DDW 2025.

In a cohort study, researchers evaluated the risk for ischemic and hemorrhagic stroke among individuals with type 1 and type ...

GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.

GLP-1 receptor agonists (GLP-1 RAs), initially developed to manage type 2 diabetes, have garnered attention for their unexpected effects on women’s health. While these medications are known for ...

The PDCO's positive opinion is based on PolTREG's original preTreg clinical trial protocol initiated in October 2024, which enrolled children aged 6-16 years in Stage 1 type 1 diabetes. In its ...

Results showed that people diagnosed with diabetes as adults had a higher risk of heart disease, as well as premature death ...

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...

Kenya is among the low- and middle-income countries (LMICs) whose children and young people (CYP) face gross inequities when ...

Discover upcoming breakthroughs in Type 1 Diabetes & B-cell disorder treatments, market growth to $24B by 2031, and key ...